They further found that methyltransferase-like 3 (METTL3), an main component in the so-called m6A ‘writer’, could promote bladder cancer progression via AFF4/NF-κB/MYC signaling network by an m6A dependent manner [10]. This evidence concerns the gene METTL3 and urinary bladder cancer.